Oncotherapeutic Application of Inhibitors of High-Affinity Glucose Transporters

The subject invention concerns materials and methods for treating oncological disorders in a person or animal using any agent or compound that inhibits uptake of glucose into a cell. The subject invention also concerns methods for inducing apoptosis and inhibiting the proliferation or survival of a cell. In one embodiment, the methods comprise administering an effective amount of an agent or compound that inhibits the activity of one or more glucose transporter proteins, such as Glut-1. An antibody that binds to and inhibits a glucose transporter protein can be used in the present methods.

Patents:
US 20,110,104,249

Inventor(s): SIMON GEORGE R [US]

Type of Offer: Licensing



« More Biotech Patents

---